Importantly, this impairment is reversible through exogenous retinol supplementation, highlighting potential therapeutic targets, such as collagen-integrin signaling and MDK-SDC4 pathways, to counteract age-related skin changes. The gene discussed is MDK; the disease is Abnormality of the skin.